Viewing nowScodrine Tablet (Orphenadrine Hydrochloride)
Orphenadrine Hydrochloride 25mg
Tablet · Prescription medication
Youngil Pharmaceutical Co., Ltd.

MFDS item code 199101918 · Notified 1991.01.29 · Insurance code 649401260
Relief of pain from skeletal muscle spasms; treatment of parkinsonism (e.g., idiopathic and postencephalitic)
This medication is used for the relief of symptoms associated with idiopathic Parkinson's disease, as well as other forms of Parkinson's disease due to encephalitis or atherosclerosis, and for relief of pain caused by skeletal muscle spasms.
(Oral: tablets) Adults: Administer 2 tablets (50㎎) of orphenadrine hydrochloride orally per dose, 3 times daily. The dose may be adjusted as appropriate according to age and symptoms. (Injection) Adults: Administer 80-120㎎ (4-6㎖) of orphenadrine hydrochloride intramuscularly per day. The dose may be adjusted as appropriate according to age and symptoms.
This medication should not be used in patients with glaucoma. Patients with obstruction in the pylorus or duodenum should also avoid this medication. Those with a constrictive peptic ulcer should refrain from this medication as well. It is advisable not to use this drug if there is benign prostatic hypertrophy or bladder neck obstruction. This medication is not suitable for patients with esophageal spasm, such as megasophagus. Patients with severe myasthenia gravis should also not take this medication. Individuals with allergic reactions to this drug should absolutely not use it. In addition, this drug contains lactose and should not be administered to patients with genetic conditions such as galactose intolerance, lactase deficiency, or glucose-galactose malabsorption. Patients with tachycardia or cardiovascular disease, as well as those with liver or kidney function issues, should use this medication cautiously. Taking this medication may result in dry mouth, increased heart rate, constipation, difficulty urinating, blurred vision, abdominal pain, drowsiness, dizziness, headaches, and skin rashes. Most of these symptoms may resolve with a reduction in dosage or discontinuation of the medication. Some patients may develop dependence on this medication, so do not suddenly discontinue use; instead, gradually reduce under a doctor's direction. The safety of this medication during pregnancy or breastfeeding is not definitively established, so it should only be used when the benefits of treatment outweigh the risks. Additionally, safety has not been sufficiently proven in children or infants, so it should only be used when absolutely necessary.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container that blocks light, and should be kept at room temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the effectiveness and safety of the medication.
Pale yellow round tablets
500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowOrphenadrine Hydrochloride 25mg
Tablet · Prescription medication
Youngil Pharmaceutical Co., Ltd.

Orphenadrine Hydrochloride 25mg
Tablet · Prescription medication
Yuyoung Pharmaceutical Co., Ltd.

Orphenadrine Hydrochloride 25mg
Tablet · Prescription medication
Samnam Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.